Spontaneous rectus sheath hematoma during rivaroxaban therapy

Kocayiğit, İbrahim; Can, Yusuf; Şahinkuş, Salih; Aydın, Ercan; Vatan, Mehmet Bülent; Kılıç, Harun; Gündüz, Hüseyin

doi:10.4103/0253-7613.132193

Cited by 16 publications

(18 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To our knowledge, only two reports that associated the formation of rectus sheath hematoma with use of the new oral anticoagulant rivaroxaban are known (3,11). Our case report is the first of its kind to highlight the association between apixaban treatment and formation of rectus sheath hematoma.…”

Section: Discussionmentioning

confidence: 65%

Spontaneous rectus sheath hematoma in a patient treated with apixaban

Aktaş

İnci

Doğan

et al. 2015

IRDR

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 65%

Spontaneous rectus sheath hematoma in a patient treated with apixaban

Aktaş

İnci

Doğan

et al. 2015

IRDR

View full text Add to dashboard Cite

“…Kocayigit et al 12 reported a spontaneous rectus sheath hematoma in a 75-year-old female treated with rivaroxaban for non-valvular atrial fibrillation, initiated 3 days prior to presentation. The patient had presented to the emergency department with complaints of fatigue and abdominal pain after rigorous coughing.…”

Section: Discussionmentioning

confidence: 99%

Rectus Sheath Hematoma Associated with Apixaban

Gunasekaran

Winans

Murthi

et al. 2017

Clinics and Practice

View full text Add to dashboard Cite

Apixaban is an oral anticoagulant that directly inhibits Factor Xa and is indicated for the prophylaxis and treatment of deep venous thrombosis and stroke prevention in non-valvular atrial fibrillation. Rectus sheath hematoma is a rare, life-threatening complication of anticoagulant treatment. We describe a case of an elderly patient on apixaban for the treatment of deep venous thrombosis who developed severe abdominal pain during hospitalization. Computed tomography of the abdomen revealed left rectus sheath hematoma. Apixaban was discontinued and the patient was monitored for extension of the hematoma. After 2 days she was discharged home. Outpatient computed tomography 1 month later showed complete resolution of the rectus sheath hematoma. We recommend that clinicians become aware of the potential for rare and serious bleeding complications of anticoagulants and identify the need for early recognition and prompt management.

show abstract

“…It is currently indicated for atrial fibrillation and prophylaxis of deep venous thrombosis. It does not require INR monitoring like warfarin [5].…”

Section: Discussionmentioning

confidence: 99%

“…Hematomas of the rectus abdominis muscle are commonly reported complications of systemic anticoagulation treatment [4]. There is a single reported case of rectus abdominis hematoma due to rivaroxaban use in the literature [5]. We did not come across any literature date on percutaneous drainage treatment of spontaneous rectus abdominis hematoma.…”

Section: Introductionmentioning

confidence: 97%

Percutaneous drainage in treatment for spontaneous rectus abdominis hematoma due to rivaroxaban usage

Doğan¹,

Dursun²

2016

Eur Res J

View full text Add to dashboard Cite

Rivaroxaban is currently used to prevent stroke in patients with atrial fibrillation. Like all anticoagulants, rivaroxaban carries a risk of bleeding. There is a single reported case of rectus abdominis hematoma due to rivaroxaban use in the literature. We present an 82-year-old female patient presented to our outpatient clinic with sudden pain and swelling in the abdominal region. The patient had been treated with rivaroxaban for three months without warfarin. Computed tomography scanning showed a 25x10x15 cm long acute hematoma in the left rectus abdominis. Rivaroxaban was replaced with enoxaparin for thromboembolus prophylaxis. We performed percutaneous drainage in order to reduce pain and recovery time by decreasing the hematoma size. Catheter drainage was used in the third day to minimize rivaroxaban activity. We did not come across any literature date on percutaneous drainage treatment of spontaneous rectus abdominis hematoma. We report a case of hematoma of the rectus abdominis muscle that occurred following rivaroxaban use and was successfully treated with percutaneous drainage.Eur Res J 2016;2(2):151-153

show abstract

Spontaneous rectus sheath hematoma during rivaroxaban therapy

Cited by 16 publications

References 6 publications

Spontaneous rectus sheath hematoma in a patient treated with apixaban

Spontaneous rectus sheath hematoma in a patient treated with apixaban

Rectus Sheath Hematoma Associated with Apixaban

Percutaneous drainage in treatment for spontaneous rectus abdominis hematoma due to rivaroxaban usage

Contact Info

Product

Resources

About